Célia Salanoubat

2.2k total citations
13 papers, 634 citations indexed

About

Célia Salanoubat is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Célia Salanoubat has authored 13 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Hematology and 4 papers in Oncology. Recurrent topics in Célia Salanoubat's work include Acute Myeloid Leukemia Research (3 papers), Natural Compound Pharmacology Studies (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Célia Salanoubat is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Natural Compound Pharmacology Studies (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Célia Salanoubat collaborates with scholars based in France and Morocco. Célia Salanoubat's co-authors include Claire Quiney, Christian Billard, Sophie Roth, Régis Peffault de Latour, Gabriel Étienne, J Cahn, Mohamad Mohty, Sébastien Maury, Gèrard Socié and Jean Yves Mary and has published in prestigious journals such as Blood, Cancer Research and Leukemia.

In The Last Decade

Célia Salanoubat

13 papers receiving 625 citations

Peers

Célia Salanoubat

HEMAT

GENET

IMMUN

NEPHR

Matthew Clement United States

Maria Radanova Bulgaria

Sercan Ergün Türkiye

Ling Pan China

Liye Zhong China

Norihisa Ishiwata Japan

Michela Asperti Italy

Terry O’Reilly United States

Mengxia Yu China

Nicole Fortenbery United States

Matthew Clement United States

Célia Salanoubat

83 ×0.3

HEMAT

144 ×0.5

GENET

193 ×0.7

IMMUN

155 ×1.1

41 ×0.3

NEPHR

Citations per year, relative to Célia Salanoubat Célia Salanoubat (= 1×) peers Matthew Clement

Countries citing papers authored by Célia Salanoubat

Since Specialization

Citations

This map shows the geographic impact of Célia Salanoubat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Célia Salanoubat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Célia Salanoubat more than expected).

Fields of papers citing papers by Célia Salanoubat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Célia Salanoubat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Célia Salanoubat. The network helps show where Célia Salanoubat may publish in the future.

Co-authorship network of co-authors of Célia Salanoubat

This figure shows the co-authorship network connecting the top 25 collaborators of Célia Salanoubat. A scholar is included among the top collaborators of Célia Salanoubat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Célia Salanoubat. Célia Salanoubat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Glaisner, Sylvie, et al.. (2023). Posterior reversible encephalopathy syndrome (PRES) and myeloma. Leukemia Research Reports. 21. 100407–100407. 1 indexed citations

Choquet, Sylvain, Magali Le Garff‐Tavernier, Laëtitia Souchet, et al.. (2022). Efficacy of CAR-T Cells in Primary Central Nervous System Lymphomas: The French Experience of the National LOC Network. Blood. 140(Supplement 1). 7540–7541. 5 indexed citations

Itzykson, Raphaël, Sylvain Thépot, Odile Beyne‐Rauzy, et al.. (2011). Does addition of erythropoiesis stimulating agents improve the outcome of higher-risk myelodysplastic syndromes treated with azacitidine?. Leukemia Research. 36(4). 397–400. 9 indexed citations

Prébet, Thomas, Thorsten Braun, Odile Beyne Rauzy, et al.. (2010). A Phase I-II Study of Vorinostat and Low Dose Cytarabine for Patients Treated for High Risk Myelodysplastic with Azacytidine Failure: The GFM-VOR2007 Study. Blood. 116(21). 4003–4003. 2 indexed citations

Thépot, Sylvain, Raphaël Itzykson, Valérie Seegers, et al.. (2010). Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM). Blood. 116(19). 3735–3742. 109 indexed citations

Latour, Régis Peffault de, Jean Yves Mary, Célia Salanoubat, et al.. (2008). Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 112(8). 3099–3106. 257 indexed citations

Quiney, Claire, Christian Billard, Anne‐Marie Faussat, Célia Salanoubat, & Jean‐Pierre Kolb. (2007). Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells. Leukemia & lymphoma. 48(8). 1587–1599. 29 indexed citations

Quiney, Claire, Christian Billard, A M Faussat, et al.. (2006). Pro-apoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia. Leukemia. 20(3). 491–497. 43 indexed citations

Quiney, Claire, Christian Billard, Célia Salanoubat, J.‐D. FOURNERON, & J.P. Kolb. (2006). Hyperforin, a new lead compound against the progression of cancer and leukemia?. Leukemia. 20(9). 1519–1525. 62 indexed citations

10.

Deglesne, Pierre‐Antoine, Nathalie Chevallier, Rémi Letestu, et al.. (2006). Survival Response to B-Cell Receptor Ligation Is Restricted to Progressive Chronic Lymphocytic Leukemia Cells Irrespective of Zap70 Expression. Cancer Research. 66(14). 7158–7166. 69 indexed citations

11.

Latour, Régis Peffault de, Jean Yves Mary, Célia Salanoubat, et al.. (2006). Paroxysmal Nocturnal Hemoglobinuria (PNH): Long-Term Epidemiological Study.. Blood. 108(11). 973–973. 1 indexed citations

12.

Chaoui, Driss, Tahar Chakroun, Françoise Robert, et al.. (2005). Reticulated platelets: a reliable measure to reduce prophylactic platelet transfusions after intensive chemotherapy. Transfusion. 45(5). 766–772. 35 indexed citations

13.

Salanoubat, Célia, et al.. (2000). Is Mantle Cell Lymphoma A Sex-Related Disease?. Leukemia & lymphoma. 37(1-2). 181–184. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact